Learn More About Echo
Independent Investment Banking for Healthcare and Life Sciences
Echo Partners is a boutique investment bank focused exclusively on healthcare and life sciences. We advise founder-owned and closely-held companies on M&A and capital raises, with genuine cross-border execution connecting clients across North America and Europe to the global buyers and capital that domestic processes miss.
Decisions That Echo
We work with founders, owners, and investors at the decisions that define a company: a sale, an acquisition, a raise, or a change of control.
Partners lead every engagement, so you work directly with the people accountable for the outcome.
Our goal is simple: make the biggest decision of your company's life the best-executed one.
By The Numbers
300+
Buyers & Investors in
Active Coverage
$500M+
in Team Transaction Value
100%
Healthcare & Life Sciences Focused
20+
Transactions Advisedby the Team
Our Expertise
Echo Partners focuses exclusively on healthcare and life sciences. We serve founder-owned and closely-held companies across three service areas, and because partners lead every engagement, the most senior people in the firm are the ones doing the work, not overseeing it.
Private Capital Markets Advisory
Private placements and growth capital, typically $10-40M raises, matched to the right investors across North America, Europe, and beyond for founder-owned life sciences companies.
Explore More
.svg)
Mergers & Acquisitions (M&A)
Full, competitive sell-side processes run into the complete buyer universe, strategic and financial, domestic and international, so nothing is left on the table.
Explore More
.svg)
Strategic Advisory
Independent counsel on capital strategy, board decisions, and unsolicited approaches, from partners who have sat across the table from the buyers now approaching you.
Explore More
Sector Clarity
Life Science Tools
Instruments, reagents and software platforms that accelerate target discovery and assay development.
CDMO / CRO
Contract development, manufacturing and research organizations that enable drug and device pipelines.
Medtech
Design and development of medical devices, implants and therapeutic delivery systems.
Medical Diagnostics
Assay, imaging and point-of-care test developers for disease detection and monitoring.
Biotech
Companies creating biologic therapies, genetic medicines and cell-based treatment platforms.
.png)
Pharmaceuticals
Small-molecule and specialty drug developers overseeing discovery, development and distribution.
Bioinformatics
Computational analysis and software tools transforming genomic and clinical data into insights.
Healthtech
Digital platforms, telemedicine and software solutions that enhance care delivery and engagement.
Healthcare Services
Clinical care, diagnostics and support services providers across outpatient and inpatient settings.
.png)
Transactions
Financial Advisor
Equity Financing
Financial Advisor
.png)
Equity Financing
$45M
Financial Advisor
.avif)
Equity Financing
$145M
Financial Advisor
Equity Financing
$55M
Financial Advisor
Equity & Debt Financing
Financial Advisor
Equity Financing
$70M
Financial Advisor
Equity Financing
$117M
Financial Advisor
Sell-Side M&A
$160M
Joint Lead Arranger
Debt Financing, Revolving Credit Facility
Financial Advisor
Sell-Side M&A
The Latest From Echo
PRESS RELEASE
May 13, 2026
2026 Q1 Healthcare Market Report
PRESS RELEASE
February 26, 2026
2025 Q4 Healthcare Market Report
The Latest From Echo
Expertise At Your Fingertips
Sign up to receive our latest industry insights, news, and more.
Oops! Something went wrong while submitting the form.
Quick Links
.svg)
Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Echo Partners is not a registered broker-dealer, and Finalis Securities LLC and Echo Partners are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.
www.echopartners.io (the "Echo Partners Website") is a website operated by Echo Partners. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product, and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities’ registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy, is subject to change without notice, and Echo Partners along with Finalis Securities LLC accepts no liability for its use or to update it or keep it current.
Investing in private placements involves a high degree of risk. These investments may be illiquid, speculative, and subject to substantial restrictions on transferability. Investors may lose all or part of their investment and should only invest capital they can afford to lose. Prospective investors should conduct their own due diligence and consult with their legal, tax, and financial advisors prior to making any investment decision. For your reference, Finalis Form Customer Relationship Summary (“Form CRS”) describes the services that we provide, how we are compensated, and other important information about Finalis Securities LLC.
©Copyright 2026. Echo Partners. All Rights Reserved.